Zaverio M. Ruggeri

Active 1975–2023

133
Papers
28,459
Citations
99
h-index
132
i10-index

Citations

Citations per year for Zaverio M. Ruggeri1977: 5 citations1978: 4 citations1979: 6 citations1980: 7 citations1981: 10 citations1982: 16 citations1983: 27 citations1984: 38 citations1985: 61 citations1986: 81 citations1987: 76 citations1988: 54 citations1989: 77 citations1990: 92 citations1991: 140 citations1992: 93 citations1993: 149 citations1994: 86 citations1995: 115 citations1996: 161 citations1997: 137 citations1998: 148 citations1999: 146 citations2000: 192 citations2001: 205 citations2002: 224 citations2003: 317 citations2004: 210 citations2005: 267 citations2006: 263 citations2007: 282 citations2008: 272 citations2009: 266 citations2010: 222 citations2011: 234 citations2012: 209 citations2013: 176 citations2014: 187 citations2015: 187 citations2016: 181 citations2017: 202 citations2018: 161 citations2019: 530 citations2020: 494 citations2021: 398 citations2022: 334 citations2023: 231 citations2024: 350 citations2025: 152 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,468 citing papers, 32.1% of this breakdownGermany: 635 citing papers, 8.3% of this breakdownUnited Kingdom: 571 citing papers, 7.4% of this breakdownChina: 544 citing papers, 7.1% of this breakdownItaly: 407 citing papers, 5.3% of this breakdownFrance: 342 citing papers, 4.5% of this breakdownNetherlands: 334 citing papers, 4.3% of this breakdownAustralia: 279 citing papers, 3.6% of this breakdownCanada: 264 citing papers, 3.4% of this breakdownJapan: 213 citing papers, 2.8% of this breakdownSwitzerland: 154 citing papers, 2% of this breakdownSweden: 105 citing papers, 1.4% of this breakdown
0%32.1%Other 17.8%

Fields

  • Medicine71.3%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Immunology and Microbiology6.9%
  • Engineering3.2%
  • Materials Science1.8%
  • Neuroscience1.5%
  • Other1.4%

Topics

  • Platelet Disorders and Treatments15.6%
  • Cell Adhesion Molecules Research6.2%
  • Blood Coagulation and Thrombosis Mechanisms4.1%
  • Blood properties and coagulation3.7%
  • Antiplatelet Therapy and Cardiovascular Diseases3.6%
  • Blood groups and transfusion3.1%
  • Other63.7%

Coauthors

All papers

Open in search
  1. Immunosurveillance of the Liver by Intravascular Effector CD8 + T Cells

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2015 cited by 322

  2. Platelets in atherothrombosis

    Authors: - Nature Medicine 2002 cited by 1,578

  3. Adhesion Mechanisms in Platelet Function

    Authors: , - Circulation Research 2007 cited by 736

  4. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Thrombosis and Haemostasis 2006 cited by 1,146

  5. Activation-independent platelet adhesion and aggregation under elevated shear stress

    Authors: , , , , - Blood 2006 cited by 412

  6. Initiation of Platelet Adhesion by Arrest onto Fibrinogen or Translocation on von Willebrand Factor

    Authors: , , - Cell 1996 cited by 1,213

  7. Von Willebrand factor, platelets and endothelial cell interactions

    Authors: - Journal of Thrombosis and Haemostasis 2003 cited by 484

  8. Gut microbiota regulate hepatic von Willebrand factor synthesis and arterial thrombus formation via Toll-like receptor-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Blood 2017 cited by 155

  9. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 320

  10. The role of von Willebrand factor in thrombus formation

    Authors: - Thrombosis Research 2007 cited by 355

  11. Platelets mediate cytotoxic T lymphocyte–induced liver damage

    Authors: , , , , , , , , - Nature Medicine 2005 cited by 355

  12. Thrombotic microangiopathy as a cause of cardiovascular toxicity from the BCR-ABL1 tyrosine kinase inhibitor ponatinib

    Authors: , , , , , , , , , , , , , , , , - Blood 2019 cited by 95

  13. Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 386

  14. Cell damage evaluation of thermal inkjet printed Chinese hamster ovary cells

    Authors: , , , - Biotechnology and Bioengineering 2010 cited by 363

  15. Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrick Tso, Patrizia Marchese, W. Sean Davidson, Shaun P. Jackson, Cheng Zhu, Zaverio M. Ruggeri, Heyu Ni - Nature Communications 2018 cited by 113

  16. Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow

    Authors: , , - Cell 1998 cited by 808

  17. Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane

    Authors: , , , , , , , , , , - Blood 2011 cited by 143

  18. Mechanisms of anti-GPIbα antibody–induced thrombocytopenia in mice

    Authors: , , , , - Blood 2020 cited by 43

  19. Integrin activation controls metastasis in human breast cancer

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 580

  20. P2X7 receptor signaling contributes to tissue factor–dependent thrombosis in mice

    Authors: , , , , - Journal of Clinical Investigation 2011 cited by 167

  21. The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi

    Authors: , , , , , , , , , , , , , - Blood 2013 cited by 152

  22. Platelet-localized FXI promotes a vascular coagulation-inflammatory circuit in arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2017 cited by 112

  23. GPIbα is required for platelet-mediated hepatic thrombopoietin generation

    Authors: , , , , , , , , , , , , , , , , , - Blood 2018 cited by 79

  24. 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE

    Authors: , , , - The Lancet 1977 cited by 610